UPDATE 3-Abbott drug, statin combo may hurt women-US study

shares close down 1 percent (Changes headline) By Esha Dey WASHINGTON, April 25 (Reuters) - A study of Abbott Laboratories' (ABT.N However, the clinical significance of the finding was unclear, the U.S. Food and Drug Administration said. About 30 percent...